Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Advanced High-grade Serous Ovarian Cancer in Blood, Ascites, Peritoneal Biopsy

NCT03922776 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT03922776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03922776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Advanced High-grade Serous Ovarian Cancer in Blood, Ascites, Peritoneal Biopsy
Lead sponsor
Centre Oscar Lambret
Phase
Not applicable
Overall status
Terminated
Start date
May 17, 2019
Completion date
July 31, 2024
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer stage iiic, fallopian tube cancer stage iv, ovarian cancer stage iiic, ovarian cancer stage iv